🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-06
Trial ID
NCT01870297
Treatments Being Tested
The purpose of the study is to learn about the safety of MK-2225, including...
Status
Completed
Location
Clinical Pharmacology of Miami (Site 0002)
Start Date
2023-11-21
Trial ID
NCT06643390
Treatment for sublesional bone loss (osteoporosis) in persons with chronic,...
Status
Active Not Recruiting
Location
Kessler Institute for Rehabilitation
Start Date
2021-03-01
Trial ID
NCT04232657
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of ixekizumab do...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2015-08
Trial ID
NCT02513550
Treatments Being Tested
Primary objective: To evaluate the safety and tolerability of single and m...
Status
Completed
Location
Diablo Clinical Research
Start Date
2010-11
Trial ID
NCT01236404
A randomized, double-blind, placebo-controlled clinical study in human leuk...
Status
Unknown
Location
Diablo Clinical Research
Start Date
2018-08-06
Trial ID
NCT03644069
A double-blind placebo-controlled study evaluating the effect of 1068nm NIR...
Status
Completed
Location
Maculume Ltd
Start Date
2017-06-01
Trial ID
NCT04568057
Treatments Being Tested
There are fewer therapeutic options for patients with active ulcerative col...
Status
Completed
Location
University of Southern California
Start Date
2012-02
Trial ID
NCT01393405
Treatments Being Tested
Anthrax Clinical Trial Objectives: To assess whether: * Anthrax vaccine (...
Status
Completed
Location
University of Alabama, Birmingham (UAB)
Start Date
2002-05
Trial ID
NCT00119067
Treatments Being Tested